Effect of Addition a Sodium Deoxycholate as an Edge Activator -for Preparation of Ondansetron HCl Tansfersomal Dispersion

Hind AbdAlameer Hadi; Ahmed Hashim Hussein

doi:10.32947/ajps.v23i4.1097

Authors

Hind AbdAlameer Hadi Pharmaceutics Department, College of Pharmacy, University of Mustansiyria, Baghdad, Iraq
Ahmed Hashim Hussein Pharmaceutics Department, College of Pharmacy, University of Alkafeel, Najaf, Iraq

DOI:

https://doi.org/10.32947/ajps.v23i4.1097

Keywords:

Edge activator, Ondansteron Hcl , phosphatidylcholine ,Transdermal route , Transfersomes , Sodium deoxycholate

Abstract

In ordinary clinical practice, poor patient compliance with oral and parenteral drug administration modalities is a prevalent problem. As a result, pharmaceutical research has developed a strong interest in the transdermal route of drug delivery.

They are non-invasive that can improve patient compliance, however, The barrier function of the skin's top layer presents the biggest challenge for transdermal delivery systems. Transfersomes are vesicles composed of phospholipids and edge activators, used to transport drug from outer skin layer into the systematic circulation through semipermeable membrane. Ondansetron is an anti-emetic medication that has been given parenterally and orally. Formulating this medication as transdermal transfersomes may provoke a great advantage in medical adherence.

Conclusion; Ondansetron has been successfully delivered transdermally by Using a transfersomal gel formulation by vortexing sonication method.

References

- Topping, C. (2000). Emergency Medicine: a Comprehensive Study Guide. Edited by Tintinalli Judith E., Kelen Gabor D., Stapczynski J. Stephan. 2000. McGraw–Hill Companies, Inc. 2127 pp.

- Koch, K. L. (2000). Unexplained nausea and vomiting. Current Treatment Options in Gastroenterology, 3(4), 303–313. DOI: https://doi.org/10.1007/s11938-000-0044-5

- Farthing, M. J. G., & Ballinger, A. B. (2001). Drug Therapy for Gastrointestinal Disease. CRC Press. DOI: https://doi.org/10.3109/9780203213858

- Soni A, Dua JS, Prasad DN. Article Reviewing Transdermal Drug Delivery System. Journal of Drug Delivery and Therapeutics. 2022 Jan 15;12(1):176–80. DOI: https://doi.org/10.22270/jddt.v12i1.5159

- Swain, S.; Beg, S.; Singh, A.; Patro, C. N.; Rao, M. E. B. Advanced techniques for penetration enhancement in transdermal drug delivery system. Curr. Drug Deliv. 2011, 8, 456–473. DOI: https://doi.org/10.2174/156720111795767979

- Benson, H. A. E. Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2005, 2, 23–33. DOI: https://doi.org/10.2174/1567201052772915

- Jiang T, Xu G, Chen G, Zheng Y, He B, Gu Z. Progress in transdermal drug delivery systems for cancer therapy. Nano Res. 2020 Jul 1;13(7):1810–24.

- Walve, J.R.; Bakliwal, S.R.; Rane, B.R.; Pawar, S.P. Transfersomes: A surrogated carrier for transdermal drug delivery system. Int. J. Appl. Biol. Pharm. Technol. 2011, 2, 204–213.

- Sachan, R.; Parashar, T.; Soniya, S.V.; Singh, G.; Tyagi, S.; Patel, C.; Gupta, A. Drug carrier transfersomes: A novel tool for transdermal drug delivery system. Int. J. Res. Dev. Pharm. Life Sci. 2013, 2, 309–316.

- Structure of transfersome. [Internet]. ResearchGate.

- Mathur, M. Approaches for improving the pharmacological and pharmacokinetics properties of herbal drugs. Int. Res. J. Pharm. Appl. Sci. 2013, 3, 40–50.

- Jadupati, M.; Kumar, N.A. Transferosome: An opportunistic carrier for transdermal drug delivery system. Int. Res. J. Pharm. 2012, 3, 35–38.

- Jiang T, Xu G, Chen G, Zheng Y, He B, Gu Z. Progress in transdermal drug delivery systems for cancer therapy. Nano Res. 2020 Jul 1;13(7):1810–24. DOI: https://doi.org/10.1007/s12274-020-2664-5

- Modi, C. D., Res, P. D. B.-A. J. P. T., & 2012, undefined. (2012). Transfersomes: new dominants for transdermal drug delivery. Researchgate.Net, 2(3).

- Piumitali, B., Neeraj, U., & Jyotivardhan, J. (2020). Transfersomes-A Nanoscience in Transdermal Drug Delivery and Its Clinical Advancements. International Journal of Nanoscience, 19(4). DOI: https://doi.org/10.1142/S0219581X19500339

- Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., … X. L.-A. journal of, & 2015, undefined. (n.d.). A review on phospholipids and their main applications in drug delivery systems. Elsevier. DOI: https://doi.org/10.1016/j.ajps.2014.09.004

- Bnyan, R., Khan, I., Ehtezazi, T., Saleem, I., Gordon, S., & Roberts, M. (n.d.). Surfactant effects on lipid-based vesicles properties. Elsevier.

- Patel, H., Patel, U., BHIMANI, B., & DASLANIYA, D. (2012). Transdermal drug delivery system as prominent dosage forms for the highly lipophilic drugs. The International Journal of Pharmaceutical Research and Bio-Science, 1(3). DOI: https://doi.org/10.31638/IJPRS.V1.I1.00018

- Markham, A., & Sorkin, E. M. (1993). Ondansetron: An Update of its Therapeutic Use in Chemotherapy-Induced and Postoperative Nausea and Vomiting. Drugs, 45(6), 931–952. DOI: https://doi.org/10.2165/00003495-199345060-00006

- Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US: Press Release

- PubChem. Ondansetron [Internet].

- Zofran (Ondansetron Hydrochloride Tablets and Solution): Uses, Dosage, Side Effects, Interactions,

- Vemula S. Formulation and Evaluation of Transdermal Films of Ondansetron Hydrochloride. MOJ Bioequivalence & Bioavailability. 2017 Jun 16;3. DOI: https://doi.org/10.15406/mojbb.2017.03.00039

- Salem, I. I., López, J. M. R., & Galán, A. C. (2001). Ondansetron hydrochloride. Profiles of Drug Substances, Excipients and Related Methodology, 27, 301–338. DOI: https://doi.org/10.1016/S0099-5428(08)60716-9

- Christofaki, M., & Papaioannou, A. (2014). Ondansetron: A review of pharmacokinetics and clinical experience in postoperative nausea and vomiting. Expert Opinion on Drug Metabolism and Toxicology, 10(3), 437–444. DOI: https://doi.org/10.1517/17425255.2014.882317

- Drug Dosages - ClinicalKey. (n.d.).

- Khan MA, Pandit J, Sultana Y, Sultana S, Ali A, Aqil M, et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Delivery. 2015 Aug 18;22(6):795–802.

- Hussein AA. Preparation and evaluation of liquid and solid self microemulsifying drug delivery system of mebendazole. Iraqi Journal of Pharmaceutical Sciences. 2014;23(1):89-100. DOI: https://doi.org/10.31351/vol23iss1pp89-100

- Vasanth S, Dubey A, G.S. R, Lewis SA, Ghate VM, El-Zahaby SA, et al. Development and Investigation of Vitamin C-Enriched Adapalene-Loaded Transfersome Gel: a Collegial Approach for the Treatment of Acne Vulgaris. AAPS PharmSciTech. 2020 Feb;21(2):61 DOI: https://doi.org/10.1208/s12249-019-1518-5

- Yang, Y.; Ou, R.; Guan, S.; Ye, X.; Hu, B.; Zhang, Y.; Lu, S.; Zhou, Y.; Yuan, Z.; Zhang, J.; et al. A novel drug delivery gel of terbinafine hydrochloride with high penetration for external use. Drug Deliv. 2014;22:1–8. DOI: https://doi.org/10.3109/10717544.2013.878856

- Khan MA, Pandit J, Sultana Y, Sultana S, Ali A, Aqil M, et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Delivery. 2015 Aug 18;22(6):795–802. DOI: https://doi.org/10.3109/10717544.2014.902146

- Dhakar RC. Transfersomes- a Novel Vesicular Carrier for Enhanced Transdermal Delivery of Stavudine: Development, Characterization and Performance Evaluation

- Chopra N, Kaushik P, Malhotra H, Sharma S, Tomar D, Mishra A.Transfersomes: A novel vesicular carrier for effective transdermal drug delivery (A review) World Journal of Pharmaceutical Research. 9(9):20.

- Oklahoma LVA Jr, Ph.D. Professor Emeritus College of Pharmacy, University of Oklahoma City. Ondansetron Hydrochloride 0.8 mg/mL Oral Liquid

- Patra S, Choudhury AA, Kar RK, Barik BB. Spectrophotometric method for ondansetron hydrochloride. Indian Journal of Pharmaceutical Sciences. 2007;69(6):840. DOI: https://doi.org/10.4103/0250-474X.39449

- Keservani RK, Sharma AK, Kesharwani RK. Novel Approaches for Drug Delivery: IGI Global; 2016. DOI: https://doi.org/10.4018/978-1-5225-0751-2

- Nayak AK, Hasnain MS, Aminabhavi T, Torchilin VP. Applications of Nanovesicular Drug Delivery: Elsevier Science; 2022. DOI: https://doi.org/10.1016/B978-0-323-91864-0.00026-7

- Bragagni M, Mennini N, Maestrelli F, Cirri M, Mura P. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Delivery. 2012;19(7):354-61. DOI: https://doi.org/10.3109/10717544.2012.724472

- Joshi, A., Kaur, J., Kulkarni, R., & Chaudhari, R. (2018). In-vitro and Ex-vivo evaluation of Raloxifene hydrochloride delivery using nano-transfersome based formulations. Journal of Drug Delivery Science and Technology, 45, 151–158. DOI: https://doi.org/10.1016/j.jddst.2018.02.006

- Ajay G, Vinit MK. Formulation and Evaluation of Ketoprofen Loaded Protransfersome by Using Sodium Deoxycholate and Brij 35.

- SAS. 2018. Statistical Analysis System, User's Guide. Statistical. Version 9.6th ed. SAS. Inst. Inc. Cary. N.C. USA.

- Hussein HAA, Maraie NK. Highlights on polymeric micelles as versatile nanocarriers for drug transporting. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2021;21(2):21–30. DOI: https://doi.org/10.32947/ajps.v21i2.806

- Al-Sakini SJ, Maraie NK. In vitro Evaluation of the Effect of Using Different Gelling agents on the Release of Erythromycin from a Nanocubosomal gel. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2019 Mar 1;19(1):34–43. DOI: https://doi.org/10.32947/ajps.v19i1.542